Companies form sales partnership to offer myoelectric orthotic technology in select markets starting January 1, 2017

AUSTIN, Texas and CAMBRIDGE, Mass. (December 19, 2016) — Ottobock, a world market leader in technical orthopedics, and Myomo, Inc., a leading manufacturer of myoelectric orthotics, have reached an agreement for Ottobock to exclusively distribute the Myomo® patented MyoPro® orthosis technology globally, starting with select markets in North America and Germany.

The MyoPro is a custom orthosis, based on technology developed at the Massachusetts Institute of Technology, that has been prescribed to help support and restore function for people who have a paralyzed arm as a result of a stroke, spinal cord injury, nerve damage such as a brachial plexus injury, or progressive conditions such as multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS or “Lou Gehrig’s Disease”).

“Ottobock is committed to providing orthotic solutions to drive successful patient outcomes and meet the needs of the orthotist,” said Chris Nolan, Vice President of Orthotics for Ottobock North America. “Our partnership with Myomo will enable Ottobock to address the unmet needs of individuals with upper extremity paralysis with the MyoPro orthotic product line. We look forward to providing this innovative technology to help people maintain or regain their freedom of movement.”

Frank Bomers, Global Head of Orthotics for Ottobock, added, “Ottobock is excited to leverage the strength of our global sales organization to represent this innovative treatment for the patients we serve.”

“We are very pleased to enter into this agreement with Ottobock, a leader in the field of orthotics and prosthetics, so that we can broaden distribution of the MyoPro product line in the U.S. and in international markets served by Ottobock. We are often contacted by clinicians and patients from around the world seeking our devices to overcome their paralysis, and we now have a partner that can assist us in helping these individuals to return to work, live independently, and reduce their healthcare costs,” said Paul R. Gudonis, CEO of Myomo.

About Ottobock: Ottobock uses innovative technology, superior service, and world-class education to help people with physical mobility challenges. Established in 1919 in Germany, Ottobock opened its doors in the U.S. in 1958 and in Canada in 1978. Currently in its third generation as a privately held company, Ottobock offers products and services to help people maintain or regain their freedom of movement.

About Myomo Inc.: Myomo, Inc. is a medical robotics company leading the way in providing myoelectric-controlled, powered braces (orthotics) that support weakened extremities. The company’s myoelectric orthotics have been prescribed to help support a limb and restore function by enabling individuals with various neurological conditions to self-initiate and control movement of their partially paralyzed limbs using their own muscle signals. The Myomo technology was originally developed at Massachusetts Institute of Technology in collaboration with medical experts affiliated with Harvard Medical School. The company is headquartered in Cambridge, Mass.

Media Contacts

Adam McPherson │Ottobock │ 512 806 2804 │ adam.mcpherson@ottobock.com

Alan Weinberg │Myomo │ 877 736 9666 │ alan@myomo.com